作者
Elliott Lilley, S Clare Stanford, David E Kendall, Stephen PH Alexander, Giuseppe Cirino, James R Docherty, Christopher H George, Paul A Insel, Angelo A Izzo, Yong Ji, Reynold A Panettieri, Christopher G Sobey, Barbara Stefanska, Gary Stephens, Mauro Teixeira, Amrita Ahluwalia
发表日期
2020/8
期刊
British journal of pharmacology
卷号
177
期号
16
页码范围
3611
出版商
Wiley
简介
1. BACKGROUND
The BJP has been and remains an active advocate of the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines (Kilkenny, Browne, Cuthill, Emerson, & Altman, 2010a) that were established by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) in 2010. The ARRIVE guidelines need no introduction and we will not rehearse the arguments in depth here, other than to restate that the lack of key in vivo experimental details has been identified as a major contributing factor to the poor reproducibility of pre‐clinical research. This fact was the primary driver for establishment by the NC3Rs of the first version of the ARRIVE guidelines.
学术搜索中的文章
E Lilley, SC Stanford, DE Kendall, SPH Alexander… - British journal of pharmacology, 2020
